August 23, 2017 8:38 PM ET

Pharmaceuticals

Company Overview of GlaxoSmithKline plc

Executive Profile

Lynn Laverty Elsenhans

Independent Non-Executive Director, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 10 different industries.

See Board Relationships
60196,000 GBP

Background

Ms. Lynn Laverty Elsenhans serves as a Director of Baker Hughes, a GE company. Ms. Elsenhans has been a Non-Executive Director of GlaxoSmithKline plc since July 1, 2012. She served as the Chief Executive Officer and President at Sunoco, Inc. from August 8, 2008 to March 1, 2012. Ms. Elsenhans served as the Chief Executive Officer of Sunoco Partners LLC and Sunoco Logistics Partners LP from July 2010 to March 1, 2012. She served as an Executive Vice President of Global ...

Corporate Headquarters

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships

Director
Director
Director
2012-Present
Independent Non-Executive Director

Education

BA 1978
Rice University
MBA 1980
Harvard Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation196,000 GBP
Total Calculated Compensation196,000 GBP
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Werner Baumann Chairman of the Board of Management and Chief Executive Officer
Bayer Aktiengesellschaft
$2.8M
Mark J. Alles CEO & Director
Celgene Corporation
$1.1M
David A. Ricks Chairman, Chief Executive Officer & President
Eli Lilly and Company
--
Lars Fruergaard Jørgensen President & CEO
Novo Nordisk A/S
$8.7M
Kurt W. Bock Chairman of the Board of Executive Directors
BASF SE
$3.9M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GlaxoSmithKline plc, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.